for healthier lives
Precision Health member Cristen Willer co-authors a preclinical study identifying a possible therapeutic target for cardiovascular risk factors that avoid the common problem of an increased risk of fatty liver disease.
Clinical trials underway are testing whether drugs that target the androgen receptor – successful in controlling prostate cancer – could also work against the coronavirus.
Researchers from the University of Michigan School of Public Health and the Jackson Laboratory for Genomic Medicine will lead an interdisciplinary, multi-institution study of the ethical, legal and social implications of workplace genomic testing in the United States. Collaborators on this study include Education & Training Workgroup member Scott Roberts and Precision Health member Kayte Spector-Bagdady.
New how-to resources and data offerings on Precision Health Analytics Platform
Researchers across campus can now directly query, via SQL server, a de-identified version of the Research Data Warehouse, which includes all 4 million unique Michigan Medicine patients. Learn how to leverage this resource and more Precision Health resources through our updated documentation site and new video demos and tutorials.
Enter our naming contest!
Precision Health is requesting your help in finding a memorable new name for our participant population: one that conveys the value and diversity of these research participants.
Brahmajee Nallamothu named new Precision Health Co-Director
We are pleased to announce that effective January 1, 2021, Brahmajee Nallamothu, MD, MPH, Professor in the Division of Cardiovascular Diseases and the Department of Internal Medicine at Michigan Medicine, will become a Co-Director of Precision Health at the University of Michigan. He will join Co-Directors Jenna Wiens, PhD, and Michael Boehnke, PhD. Nallamothu will succeed Sachin Kheterpal, MD, MBA, who is stepping down as Co-Director.